ORAXOL Trademark

Trademark Overview


On Friday, February 12, 2016, a trademark application was filed for ORAXOL with the United States Patent and Trademark Office. The USPTO has given the ORAXOL trademark a serial number of 86905851. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, February 15, 2017. This trademark is owned by Hanmi Pharmaceutical Co. Ltd.. The ORAXOL trademark is filed in the Pharmaceutical Products category with the following description:

Orally delivered oncology drug
oraxol

General Information


Serial Number86905851
Word MarkORAXOL
Filing DateFriday, February 12, 2016
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, February 15, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements


Goods and ServicesOrally delivered oncology drug

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, February 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHanmi Pharmaceutical Co. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGyeonggi-do
KR

Party NameHanmi Pharmaceutical Co. Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGyeonggi-do
KR

Trademark Events


Event DateEvent Description
Wednesday, February 15, 2017ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Wednesday, February 15, 2017ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, February 15, 2017OPPOSITION TERMINATED NO. 999999
Wednesday, February 15, 2017OPPOSITION SUSTAINED NO. 999999
Wednesday, November 2, 2016OPPOSITION INSTITUTED NO. 999999
Thursday, July 28, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 31, 2016ASSIGNED TO EXAMINER
Tuesday, March 29, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 29, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 16, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords


oraxol drug oncology delivered orally